Furthermore, our in vitro and in vivo results revealed that RFPL3 knockdown inhibited lung cancer cell growth and the genetic–clinicopathologic correlation analysis found that upregulation of RFPL3 was significantly associated with shorter OS of patients with lung adenocarcinomas. Here, RFPL3 is linked to lung adenocarcinoma.